G P Jacobs1, P Bhat2, P Owiti3,4, J K Edwards5,6, H Tweya4,7, R Najjemba8. 1. Ministry of Health, Monrovia, Liberia. 2. Ministry of Health, Government of Karnataka, Bangalore, India. 3. Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya. 4. International Union Against Tuberculosis and Lung Disease, Paris, France. 5. Médecins Sans Frontières, Brussels, Belgium. 6. Johns Hopkins University, School of Public Health, Baltimore, Maryland, USA. 7. The Lighthouse Trust, Lilongwe, Malawi. 8. Makerere University College of Health Sciences, Kampala, Uganda.
Abstract
Setting: Health facilities providing human immunodeficiency virus (HIV) testing, care and treatment in Liberia. Objective: To evaluate individuals aged ⩾15 years who were tested, diagnosed and enrolled into HIV care before (2013), during (2014) and after the Ebola outbreak (2015). Design: A cross-sectional descriptive study. Results: A median of 6930 individuals aged ⩾15 years per county were tested for HIV before the Ebola outbreak; this number declined by 35% (2444/6930) during the outbreak. HIV positivity remained similar before (7028/207 314, 3.4%) and during the outbreak (4146/121 592, 3.5%). During Ebola, HIV testing declined more in highly affected counties (68 035/127 468, 47%) than in counties that were less affected (16 444/23 955, 31%, P < 0.001). Compared to the pre-Ebola period, HIV testing in less-affected counties recovered more quickly during the post-outbreak period, with a 19% increase in testing, while medium and highly affected counties remained at respectively 38% and 48% below pre-outbreak levels. Enrolment for HIV care increased during and after the outbreak compared to the pre-Ebola period. Conclusion: HIV testing and diagnosis were significantly limited during the Ebola outbreak, with the most severe effects occurring in highly affected counties. However, enrolment for HIV care and treatment were resilient throughout the outbreak. Pro-active measures are needed to sustain HIV testing rates in future epidemics.
Setting: Health facilities providing human immunodeficiency virus (HIV) testing, care and treatment in Liberia. Objective: To evaluate individuals aged ⩾15 years who were tested, diagnosed and enrolled into HIV care before (2013), during (2014) and after the Ebola outbreak (2015). Design: A cross-sectional descriptive study. Results: A median of 6930 individuals aged ⩾15 years per county were tested for HIV before the Ebola outbreak; this number declined by 35% (2444/6930) during the outbreak. HIV positivity remained similar before (7028/207 314, 3.4%) and during the outbreak (4146/121 592, 3.5%). During Ebola, HIV testing declined more in highly affected counties (68 035/127 468, 47%) than in counties that were less affected (16 444/23 955, 31%, P < 0.001). Compared to the pre-Ebola period, HIV testing in less-affected counties recovered more quickly during the post-outbreak period, with a 19% increase in testing, while medium and highly affected counties remained at respectively 38% and 48% below pre-outbreak levels. Enrolment for HIV care increased during and after the outbreak compared to the pre-Ebola period. Conclusion:HIV testing and diagnosis were significantly limited during the Ebola outbreak, with the most severe effects occurring in highly affected counties. However, enrolment for HIV care and treatment were resilient throughout the outbreak. Pro-active measures are needed to sustain HIV testing rates in future epidemics.
Entities:
Keywords:
ART; Africa; HIV care; SORT IT; operational research
Authors: M Edginton; D Enarson; R Zachariah; T Reid; S Satyanarayana; K Bissell; S G Hinderaker; T Harries Journal: Public Health Action Date: 2012-03-21
Authors: R Zachariah; N Ortuno; V Hermans; W Desalegn; S Rust; A J Reid; M J Boeree; A D Harries Journal: Int J Tuberc Lung Dis Date: 2015-11 Impact factor: 2.373
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Lancet Date: 2007-10-20 Impact factor: 79.321
Authors: David Leuenberger; Jean Hebelamou; Stefan Strahm; Nathalie De Rekeneire; Eric Balestre; Gilles Wandeler; François Dabis Journal: AIDS Date: 2015-09-10 Impact factor: 4.177
Authors: Augustine Talumba Choko; Nicola Desmond; Emily L Webb; Kondwani Chavula; Sue Napierala-Mavedzenge; Charlotte A Gaydos; Simon D Makombe; Treza Chunda; S Bertel Squire; Neil French; Victor Mwapasa; Elizabeth L Corbett Journal: PLoS Med Date: 2011-10-04 Impact factor: 11.069
Authors: Amitabh B Suthar; Nathan Ford; Pamela J Bachanas; Vincent J Wong; Jay S Rajan; Alex K Saltzman; Olawale Ajose; Ade O Fakoya; Reuben M Granich; Eyerusalem K Negussie; Rachel C Baggaley Journal: PLoS Med Date: 2013-08-13 Impact factor: 11.069
Authors: Bradley H Wagenaar; Orvalho Augusto; Jason Beste; Stephen J Toomay; Eugene Wickett; Nelson Dunbar; Luke Bawo; Chea Sanford Wesseh Journal: PLoS Med Date: 2018-02-20 Impact factor: 11.069
Authors: Pruthu Thekkur; Kudakwashe C Takarinda; Collins Timire; Charles Sandy; Tsitsi Apollo; Ajay M V Kumar; Srinath Satyanarayana; Hemant D Shewade; Mohammed Khogali; Rony Zachariah; I D Rusen; Selma Dar Berger; Anthony D Harries Journal: Trop Med Infect Dis Date: 2021-05-31
Authors: Irene Mbithi; Pruthu Thekkur; Jeremiah Muhwa Chakaya; Elizabeth Onyango; Philip Owiti; Ngugi Catherine Njeri; Ajay M V Kumar; Srinath Satyanarayana; Hemant D Shewade; Mohammed Khogali; Rony Zachariah; I D Rusen; Selma Dar Berger; Anthony D Harries Journal: Trop Med Infect Dis Date: 2021-05-10
Authors: Pruthu Thekkur; Hannock Tweya; Sam Phiri; James Mpunga; Thokozani Kalua; Ajay M V Kumar; Srinath Satyanarayana; Hemant D Shewade; Mohammed Khogali; Rony Zachariah; I D Rusen; Selma Dar Berger; Anthony D Harries Journal: Trop Med Infect Dis Date: 2021-05-19